4
Changes in Ownership
Indaptus Therapeutics, Inc. Filed Acc 0001493152-24-003449
Options or other derivatives
- Chief Medical Officer acquired 75,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Waltzman Roger J. Chief Medical Officer | 2024-01-22 | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | D | ||
Loading xslF345X05/ownership.xml…